首页> 外文期刊>Current opinion in HIV and AIDS >Elite controllers as a model of functional cure.
【24h】

Elite controllers as a model of functional cure.

机译:精英控制器作为功能治愈的典范。

获取原文
获取原文并翻译 | 示例
           

摘要

PURPOSE OF REVIEW: The limitations of life-long antiretroviral therapies for the HIV infection lead to a novel concept of a functional cure developing innovative therapeutic strategies to generate a long-term remission of HIV replication without treatment. This concept requires an understanding of the mechanisms by which HIV is controlled in conditions of undetectable virus replication, before developing ambitious therapies blocking durably viral replication - and ultimately eradicating HIV. RECENT FINDINGS: Recent literature shows that the exceptional elite controller status is usually not driven by virus gross genetic defects, despite some virus attenuation resulting from immune selective pressure, but is frequently determined by host's genetic factors permitting robust cell-mediated immunity to control the virus replication and reservoirs. Lack of immunity and immune deficiency can however limit this model in some cases and only a subgroup in whom both the virus and the immune deficiency are controlled, that is the elite long-term controllers, might represent the best current model for a functional cure. SUMMARY: This review examines whether the exceptional HIV-infected elite controllers, who spontaneously and durably maintain extremely low virus replication, might be considered as a model for a functional cure and whether the mechanisms identified in these exceptional individuals might serve to identify therapeutic or vaccine strategies.
机译:审查的目的:终身抗逆转录病毒疗法对HIV感染的局限性导致了功能性疗法的新概念,该功能性疗法开发了创新的治疗策略,可在不进行治疗的情况下使HIV复制长期缓解。这个概念需要了解在无法检测到的病毒复制条件下控制HIV的机制,然后再制定出雄心勃勃的疗法来阻止持久的病毒复制-最终消灭HIV。最近的发现:尽管有免疫选择压力导致某些病毒减毒,但最近的文献表明,特殊的精英控制者地位通常不是由病毒总的遗传缺陷驱动的,而是经常由宿主的遗传因素决定的,这些遗传因素允许强大的细胞介导的免疫力来控制病毒复制和储存。但是,在某些情况下,缺乏免疫力和免疫缺陷会限制该模型,只有一个同时控制病毒和免疫缺陷的亚组(即精英长期控制者)才可能代表目前用于功能治愈的最佳模型。简介:这项审查检查了是否可以将自发且持续保持极低病毒复制的异常HIV感染精英控制者视为功能治愈的模型,以及在这些异常个体中确定的机制是否可以用于鉴定治疗或疫苗策略。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号